| mRNA |
BMS-509744 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.05 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.05 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
| mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
| mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.05 |
| mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.06 |
| mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.063 |
0.06 |
| mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.06 |
| mRNA |
STF-62247 |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.06 |
| mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.06 |